Mammary-Stem-Cell-Based Somatic Mouse Models Reveal Breast Cancer Drivers Causing Cell Fate Dysregulation

Zheng Zhang, John R. Christin, Chunhui Wang, Kai Ge, Maja H. Oktay, Wenjun Guo

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Cancer genomics has provided an unprecedented opportunity for understanding genetic causes of human cancer. However, distinguishing which mutations are functionally relevant to cancer pathogenesis remains a major challenge. We describe here a mammary stem cell (MaSC) organoid-based approach for rapid generation of somatic genetically engineered mouse models (GEMMs). By using RNAi and CRISPR-mediated genome engineering in MaSC-GEMMs, we have discovered that inactivation of Ptpn22 or Mll3, two genes mutated in human breast cancer, greatly accelerated PI3K-driven mammary tumorigenesis. Using these tumor models, we have also identified genetic alterations promoting tumor metastasis and causing resistance to PI3K-targeted therapy. Both Ptpn22 and Mll3 inactivation resulted in disruption of mammary gland differentiation and an increase in stem cell activity. Mechanistically, Mll3 deletion enhanced stem cell activity through activation of the HIF pathway. Thus, our study has established a robust in vivo platform for functional cancer genomics and has discovered functional breast cancer mutations.

Original languageEnglish (US)
Pages (from-to)3146-3156
Number of pages11
JournalCell Reports
Volume16
Issue number12
DOIs
StatePublished - Sep 20 2016

Fingerprint

Adult Stem Cells
Stem cells
Breast
Breast Neoplasms
Phosphatidylinositol 3-Kinases
Tumors
Clustered Regularly Interspaced Short Palindromic Repeats
Genes
Neoplasms
Stem Cells
Genomics
Chemical activation
Organoids
Mutation
Medical Genetics
Human Mammary Glands
Carcinogenesis
Genome
Neoplasm Metastasis

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Mammary-Stem-Cell-Based Somatic Mouse Models Reveal Breast Cancer Drivers Causing Cell Fate Dysregulation. / Zhang, Zheng; Christin, John R.; Wang, Chunhui; Ge, Kai; Oktay, Maja H.; Guo, Wenjun.

In: Cell Reports, Vol. 16, No. 12, 20.09.2016, p. 3146-3156.

Research output: Contribution to journalArticle

Zhang, Zheng ; Christin, John R. ; Wang, Chunhui ; Ge, Kai ; Oktay, Maja H. ; Guo, Wenjun. / Mammary-Stem-Cell-Based Somatic Mouse Models Reveal Breast Cancer Drivers Causing Cell Fate Dysregulation. In: Cell Reports. 2016 ; Vol. 16, No. 12. pp. 3146-3156.
@article{27785ec566cf488886727295de84a2e4,
title = "Mammary-Stem-Cell-Based Somatic Mouse Models Reveal Breast Cancer Drivers Causing Cell Fate Dysregulation",
abstract = "Cancer genomics has provided an unprecedented opportunity for understanding genetic causes of human cancer. However, distinguishing which mutations are functionally relevant to cancer pathogenesis remains a major challenge. We describe here a mammary stem cell (MaSC) organoid-based approach for rapid generation of somatic genetically engineered mouse models (GEMMs). By using RNAi and CRISPR-mediated genome engineering in MaSC-GEMMs, we have discovered that inactivation of Ptpn22 or Mll3, two genes mutated in human breast cancer, greatly accelerated PI3K-driven mammary tumorigenesis. Using these tumor models, we have also identified genetic alterations promoting tumor metastasis and causing resistance to PI3K-targeted therapy. Both Ptpn22 and Mll3 inactivation resulted in disruption of mammary gland differentiation and an increase in stem cell activity. Mechanistically, Mll3 deletion enhanced stem cell activity through activation of the HIF pathway. Thus, our study has established a robust in vivo platform for functional cancer genomics and has discovered functional breast cancer mutations.",
author = "Zheng Zhang and Christin, {John R.} and Chunhui Wang and Kai Ge and Oktay, {Maja H.} and Wenjun Guo",
year = "2016",
month = "9",
day = "20",
doi = "10.1016/j.celrep.2016.08.048",
language = "English (US)",
volume = "16",
pages = "3146--3156",
journal = "Cell Reports",
issn = "2211-1247",
publisher = "Cell Press",
number = "12",

}

TY - JOUR

T1 - Mammary-Stem-Cell-Based Somatic Mouse Models Reveal Breast Cancer Drivers Causing Cell Fate Dysregulation

AU - Zhang, Zheng

AU - Christin, John R.

AU - Wang, Chunhui

AU - Ge, Kai

AU - Oktay, Maja H.

AU - Guo, Wenjun

PY - 2016/9/20

Y1 - 2016/9/20

N2 - Cancer genomics has provided an unprecedented opportunity for understanding genetic causes of human cancer. However, distinguishing which mutations are functionally relevant to cancer pathogenesis remains a major challenge. We describe here a mammary stem cell (MaSC) organoid-based approach for rapid generation of somatic genetically engineered mouse models (GEMMs). By using RNAi and CRISPR-mediated genome engineering in MaSC-GEMMs, we have discovered that inactivation of Ptpn22 or Mll3, two genes mutated in human breast cancer, greatly accelerated PI3K-driven mammary tumorigenesis. Using these tumor models, we have also identified genetic alterations promoting tumor metastasis and causing resistance to PI3K-targeted therapy. Both Ptpn22 and Mll3 inactivation resulted in disruption of mammary gland differentiation and an increase in stem cell activity. Mechanistically, Mll3 deletion enhanced stem cell activity through activation of the HIF pathway. Thus, our study has established a robust in vivo platform for functional cancer genomics and has discovered functional breast cancer mutations.

AB - Cancer genomics has provided an unprecedented opportunity for understanding genetic causes of human cancer. However, distinguishing which mutations are functionally relevant to cancer pathogenesis remains a major challenge. We describe here a mammary stem cell (MaSC) organoid-based approach for rapid generation of somatic genetically engineered mouse models (GEMMs). By using RNAi and CRISPR-mediated genome engineering in MaSC-GEMMs, we have discovered that inactivation of Ptpn22 or Mll3, two genes mutated in human breast cancer, greatly accelerated PI3K-driven mammary tumorigenesis. Using these tumor models, we have also identified genetic alterations promoting tumor metastasis and causing resistance to PI3K-targeted therapy. Both Ptpn22 and Mll3 inactivation resulted in disruption of mammary gland differentiation and an increase in stem cell activity. Mechanistically, Mll3 deletion enhanced stem cell activity through activation of the HIF pathway. Thus, our study has established a robust in vivo platform for functional cancer genomics and has discovered functional breast cancer mutations.

UR - http://www.scopus.com/inward/record.url?scp=84991358595&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84991358595&partnerID=8YFLogxK

U2 - 10.1016/j.celrep.2016.08.048

DO - 10.1016/j.celrep.2016.08.048

M3 - Article

C2 - 27653681

AN - SCOPUS:84991358595

VL - 16

SP - 3146

EP - 3156

JO - Cell Reports

JF - Cell Reports

SN - 2211-1247

IS - 12

ER -